N. Renée

3.6k total citations
65 papers, 2.6k citations indexed

About

N. Renée is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N. Renée has authored 65 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 22 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N. Renée's work include Colorectal Cancer Treatments and Studies (31 papers), Cancer Treatment and Pharmacology (18 papers) and Pancreatic and Hepatic Oncology Research (12 papers). N. Renée is often cited by papers focused on Colorectal Cancer Treatments and Studies (31 papers), Cancer Treatment and Pharmacology (18 papers) and Pancreatic and Hepatic Oncology Research (12 papers). N. Renée collaborates with scholars based in France, United States and Spain. N. Renée's co-authors include G. Milano, M C Etienne, F Démard, M. Schneider, Antoine Thyss, Patricia Formento, A. Thyss, O. Dassonville, Ronald A. Fleming and Jean–Louis Fischel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

N. Renée

63 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Renée France 23 2.0k 752 622 483 243 65 2.6k
M C Etienne France 27 2.1k 1.0× 859 1.1× 598 1.0× 383 0.8× 276 1.1× 54 2.8k
L B Grochow United States 32 2.2k 1.1× 1.8k 2.4× 523 0.8× 276 0.6× 344 1.4× 48 3.6k
Linda Janisch United States 23 2.1k 1.1× 1.7k 2.3× 738 1.2× 245 0.5× 257 1.1× 68 3.6k
Heinz-Josef Lenz United States 9 2.1k 1.0× 941 1.3× 821 1.3× 669 1.4× 542 2.2× 14 2.7k
Samir D. Undevia United States 21 1.3k 0.7× 1.1k 1.4× 809 1.3× 182 0.4× 195 0.8× 49 2.4k
Philip J. Gold United States 22 1.4k 0.7× 633 0.8× 760 1.2× 367 0.8× 449 1.8× 64 2.2k
D. Machover France 22 1.5k 0.7× 436 0.6× 616 1.0× 446 0.9× 335 1.4× 85 2.3k
S E Sartorius United States 19 1.8k 0.9× 1.0k 1.3× 399 0.6× 156 0.3× 233 1.0× 26 2.4k
André Planting Netherlands 31 1.6k 0.8× 923 1.2× 720 1.2× 196 0.4× 362 1.5× 71 2.6k
Wataru Ichikawa Japan 28 1.5k 0.7× 699 0.9× 1.2k 1.9× 345 0.7× 620 2.6× 136 2.7k

Countries citing papers authored by N. Renée

Since Specialization
Citations

This map shows the geographic impact of N. Renée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Renée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Renée more than expected).

Fields of papers citing papers by N. Renée

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Renée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Renée. The network helps show where N. Renée may publish in the future.

Co-authorship network of co-authors of N. Renée

This figure shows the co-authorship network connecting the top 25 collaborators of N. Renée. A scholar is included among the top collaborators of N. Renée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Renée. N. Renée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milano, G., Patricia Formento, Sarah Giacometti, et al.. (2011). Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants. Fundamental and Clinical Pharmacology. 26(4). 530–537. 11 indexed citations
2.
Dalenc, Florence, Sophie Doisneau-Sixou, Ben Allal, et al.. (2010). Tipifarnib Plus Tamoxifen in Tamoxifen-Resistant Metastatic Breast Cancer: A Negative Phase II and Screening of Potential Therapeutic Markers by Proteomic Analysis. Clinical Cancer Research. 16(4). 1264–1271. 21 indexed citations
3.
Renée, N., et al.. (2008). Optimized blood sampling with cytidine deaminase inhibitor for improved analysis of capecitabine metabolites. Journal of Chromatography B. 870(1). 117–120. 11 indexed citations
4.
Renée, N., et al.. (2007). Chronopharmacokinetics of Oral Tegafur and Uracil in Colorectal Cancer Patients. Clinical Pharmacology & Therapeutics. 83(3). 413–415. 17 indexed citations
5.
Magné, Nicolas, Marie-Christine Étienne-Grimaldi, L. Cals, et al.. (2007). Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU‐related toxicity. British Journal of Clinical Pharmacology. 64(2). 237–240. 30 indexed citations
6.
Ciccolini, Joseph, Marie-Christine Étienne-Grimaldi, N. Renée, et al.. (2005). Predicting dihydropyrimidine deshydrogenase (DPD) deficiency in cancer patients: Enzymatic activity in lymphocytes vs uracil/dihydrouracil (U/UH2) ratio determination in plasma. Cancer Research. 65. 942–942. 2 indexed citations
7.
Magné, Nicolas, J-L Fischel, Céline Tiffon, et al.. (2003). Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil. British Journal of Cancer. 89(3). 585–592. 66 indexed citations
8.
Chatelut, Étienne, Xavier Pivot, Josiane Otto, et al.. (2000). A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage. European Journal of Cancer. 36(2). 264–269. 41 indexed citations
9.
Milano, G., M C Etienne, Valérie Pierrefite‐Carle, et al.. (1999). Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity. British Journal of Cancer. 79(3-4). 627–630. 213 indexed citations
10.
Chéradame, S., M Chazal, Jean–Louis Fischel, et al.. (1999). Variable intrinsic sensitivity of human tumor cell lines to raltitrexed (Tomudex®) and folylpolyglutamate synthetase activity. Anti-Cancer Drugs. 10(5). 505–510. 4 indexed citations
11.
Fischel, Jean–Louis, Patricia Formento, Marie‐Christine Etienne, et al.. (1997). Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor. Biochemical Pharmacology. 53(11). 1703–1709. 14 indexed citations
12.
Fischel, Jean–Louis, M C Etienne, T Spector, et al.. (1995). Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.. PubMed. 1(9). 991–6. 57 indexed citations
13.
Milano, G., M C Etienne, N. Renée, et al.. (1994). Relationship between fluorouracil systemic exposure and tumor response and patient survival.. Journal of Clinical Oncology. 12(6). 1291–1295. 134 indexed citations
14.
Milano, G., M Gaspard, A. Thyss, et al.. (1993). Dihydropyrimidine dehydrogenase activity in cancer patients. European Journal of Cancer. 29(5). 740–744. 69 indexed citations
15.
Etienne, M C, G. Milano, Marc Frénay, et al.. (1992). Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients.. Journal of Clinical Oncology. 10(7). 1176–1182. 16 indexed citations
16.
Milano, G., M C Etienne, E. Cassuto‐Viguier, et al.. (1992). Influence of sex and age on fluorouracil clearance.. Journal of Clinical Oncology. 10(7). 1171–1175. 213 indexed citations
17.
Etienne, M C, et al.. (1992). No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion. British Journal of Cancer. 66(4). 668–672. 35 indexed citations
18.
Santini, J., G. Milano, Antoine Thyss, et al.. (1989). 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer. British Journal of Cancer. 59(2). 287–290. 143 indexed citations
19.
Frénay, Marc, G. Milano, N. Renée, et al.. (1989). Pharmacokinetics of weekly low dose doxorubicin. European Journal of Cancer and Clinical Oncology. 25(2). 191–195. 12 indexed citations
20.
Thyss, A., et al.. (1987). Effect of dose and repeat intravenous 24 hr infusions of methotrexate on cerebrospinal fluid availability in children with hematological malignancies. European Journal of Cancer and Clinical Oncology. 23(6). 843–847. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M C Etienne Breakdown of academic impact, for papers by L B Grochow Breakdown of academic impact, for papers by Linda Janisch Breakdown of academic impact, for papers by Heinz-Josef Lenz Breakdown of academic impact, for papers by Samir D. Undevia Breakdown of academic impact, for papers by Philip J. Gold Breakdown of academic impact, for papers by D. Machover Breakdown of academic impact, for papers by S E Sartorius Breakdown of academic impact, for papers by André Planting Breakdown of academic impact, for papers by Wataru Ichikawa
Rankless by CCL
2026